AlenCiken

Achieving Highest Complete Remission Rate of Any Lupus Study

Education
NASDAQ:AUPH   Aurinia Pharmaceuticals Inc

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.